Clearmind Medicine/$CMND
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Clearmind Medicine
Clearmind Medicine Inc is a clinical-stage pharmaceutical company engaged in Phase I/IIa clinical trials of novel psychedelic medicines. The Company focuses on developing treatments for mental health disorders, including alcohol use disorder (AUD), binge drinking, and eating disorders. Its activities are centered on the research and development of 5-methoxy-2-aminoindane (MEAI). It operates through a single research and development segment, which is conducted in Israel.
Ticker
$CMND
Sector
Primary listing
Employees
-
Headquarters
Vancouver, Canada
Website
CMND Metrics
BasicAdvanced
$2.5m
-
-$170.45
-1.12
-
Price and volume
Market cap
$2.5m
Beta
-1.12
52-week high
$2.70
52-week low
$2.10
Financial strength
Current ratio
3.794
Quick ratio
3.712
Total debt to equity
0.097
Interest coverage (TTM)
-524.54%
Profitability
EBITDA (TTM)
-7.82
Effective tax rate (TTM)
-0.53%
Management effectiveness
Return on assets (TTM)
-55.21%
Return on equity (TTM)
-119.72%
Valuation
Price to book
0.05
Price to tangible book (TTM)
0.05
Price to free cash flow (TTM)
-0.017
Free cash flow yield (TTM)
-5,750.43%
Free cash flow per share (TTM)
-142.571
Growth
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs